Cargando…
Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
Glaucoma, the leading cause of irreversible blindness worldwide, is a chronic and progressive optic neuropathy characterized by damage to the optic and retinal nerve fiber layers, which can lead to permanent loss of peripheral or central vision. Reduction of intraocular pressure (IOP) is the only kn...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640453/ https://www.ncbi.nlm.nih.gov/pubmed/37837578 http://dx.doi.org/10.1007/s40123-023-00820-y |